Kiyoki Kitagawa Selected Research

Kiyoki Kitagawa Research Topics

Disease

6	Proteinuria 12/2022 - 01/2013
5	Fibrosis (Cirrhosis) 01/2021 - 04/2004
5	Glomerulonephritis 06/2020 - 06/2002
3	Hematuria 12/2022 - 01/2013
3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021 - 01/2005
3	Chronic Kidney Failure (Chronic Renal Failure) 10/2020 - 06/2013
2	Nephrotic Syndrome (Syndrome, Nephrotic) 12/2022 - 12/2018
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 07/2020
2	Diabetes Mellitus 11/2020 - 01/2007
2	Infections 10/2016 - 01/2016
2	Rheumatoid Arthritis 01/2016 - 12/2015
2	Ureteral Obstruction 01/2007 - 07/2004
2	Reperfusion Injury 10/2003 - 04/2003
1	Collagen Diseases (Collagen Disease) 12/2021
1	Atrophy 01/2021
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 03/2020
1	Vasculitis (Vasculitides) 03/2020
1	Microscopic Polyangiitis 10/2016
1	Hepatitis 01/2016
1	Viremia 01/2016
1	Autoimmune Diseases (Autoimmune Disease) 01/2016
1	Chronic Renal Insufficiency 10/2014
1	Albuminuria 11/2013
1	Diabetic Retinopathy (Retinopathy, Diabetic) 11/2013
1	Wilms Tumor (Wilm's Tumor) 06/2013
1	Hypertension (High Blood Pressure) 06/2011
1	Granuloma 10/2010
1	Neurosarcoidosis 10/2010
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 09/2010
1	Pure Red-Cell Aplasia 09/2008
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 09/2008
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 09/2008
1	Anemia 09/2008
1	Hypoparathyroidism 01/2007
1	Bone Diseases (Bone Disease) 01/2007
1	Ischemia 10/2003
1	Necrosis 10/2003
1	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 06/2002
1	Convalescence 06/2002

Drug/Important Bio-Agent (IBA)

4	CreatinineIBA 12/2022 - 06/2020
4	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2005 - 04/2003
3	Proteins (Proteins, Gene)FDA Link 12/2022 - 10/2003
3	Hemoglobins (Hemoglobin)IBA 01/2021 - 11/2013
3	propagermanium (Ge 132)IBA 07/2020 - 10/2003
3	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 03/2020 - 01/2013
3	Monocyte Chemoattractant ProteinsIBA 07/2004 - 04/2003
2	AlbuminsIBA 07/2020 - 12/2013
2	AutoantibodiesIBA 03/2020 - 09/2008
2	Monoclonal AntibodiesIBA 01/2016 - 01/2007
2	Messenger RNA (mRNA)IBA 06/2011 - 10/2003
2	Collagen Type I (Type I Collagen)IBA 06/2011 - 04/2004
2	Therapeutic UsesIBA 01/2007 - 04/2003
2	RS 504393IBA 07/2004 - 10/2003
2	CCR2 ReceptorsIBA 07/2004 - 04/2004
1	Serum AlbuminIBA 12/2022
1	CC ChemokinesIBA 07/2020
1	Erythropoietin Receptors (Erythropoietin Receptor)IBA 03/2020
1	AntibodiesIBA 03/2020
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2016
1	tocilizumab (atlizumab)FDA Link 01/2016
1	Ganciclovir (Cytovene)FDA LinkGeneric 01/2016
1	Methotrexate (Mexate)FDA LinkGeneric 12/2015
1	golimumab FDA Link 12/2015
1	Polysaccharides (Glycans)IBA 12/2015
1	Keratins (Keratin)IBA 06/2013
1	Prednisolone (Predate)FDA LinkGeneric 01/2013
1	Peroxidase (Myeloperoxidase)IBA 01/2013
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 10/2011
1	Procollagen Type IIBA 06/2011
1	Acetates (Acetic Acid Esters)FDA Link 06/2011
1	Desoxycorticosterone (Deoxycorticosterone)IBA 06/2011
1	SaltsIBA 06/2011
1	Transforming Growth Factors (Transforming Growth Factor)IBA 06/2011
1	Chemokine CX3CL1IBA 06/2011
1	Desoxycorticosterone Acetate (DOCA)FDA Link 06/2011
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2010
1	Rituximab (Mabthera)FDA Link 09/2010
1	Erythropoietin FDA Link 09/2008
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2007
1	Parathyroid Hormone (Parathormone)IBA 01/2007
1	Calcium Carbonate (Limestone)FDA Link 01/2007
1	CalciumIBA 01/2007
1	Sevelamer (RenaGel)FDA Link 01/2007
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2007
1	Phosphates (Orthophosphate)IBA 01/2007
1	Vitamin D FDA LinkGeneric 01/2007
1	Hydroxyproline (4 Hydroxyproline)IBA 01/2007
1	Mitogen-Activated Protein KinasesIBA 01/2005
1	N 30IBA 01/2005
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2005
1	Transforming Growth Factor beta (TGF-beta)IBA 04/2004
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 10/2003
1	p38 Mitogen-Activated Protein KinasesIBA 06/2002
1	NF-kappa B (NF-kB)IBA 06/2002
1	GlucocorticoidsIBA 06/2002

Therapy/Procedure

5	Therapeutics 12/2021 - 06/2002
1	Blood Component Removal (Apheresis) 12/2021
1	Kidney Transplantation 09/2010
1	Renal Dialysis (Hemodialysis) 01/2007